Review
doi: 10.1111/j.1559-4564.2007.05950.x.
C-reactive protein in cardiovascular risk assessment: a review of the evidence
Affiliations
- PMID: 17684461
- DOI: 10.1111/j.1559-4564.2007.05950.x
Item in Clipboard
Review
C-reactive protein in cardiovascular risk assessment: a review of the evidence
J Cardiometab Syndr.
2007 Spring.
Abstract
C-reactive protein (CRP) is an inflammatory biomarker that is strongly associated with coronary heart disease, inflammation, and the metabolic syndrome. Large-scale prospective cohort trials have shown that measurement of CRP may add predictive accuracy to the Framingham risk score, but interpretation of these data are conflicting. In the primary prevention setting, CRP can be used to reclassify patients in low or intermediate Framingham risk score groups to a higher risk category, thus making them eligible for more intensive pharmacologic interventions.
Similar articles
-
High-sensitivity C-reactive protein: a useful marker for cardiovascular disease risk prediction and the metabolic syndrome.Clin Chem. 2005 Mar;51(3):504-5. doi: 10.1373/clinchem.2004.044990. Clin Chem. 2005. PMID: 15738514 No abstract available.
-
C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile?J Cardiometab Syndr. 2006 Winter;1(1):66-9; quiz 70-1. doi: 10.1111/j.0197-3118.2006.05340.x. J Cardiometab Syndr. 2006. PMID: 17675894 Review.
-
Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease.Circ J. 2008 Dec;72(12):2046-50. doi: 10.1253/circj.cj-08-0337. Epub 2008 Oct 21. Circ J. 2008. PMID: 18946171
-
Interrelationships between inflammation, C-reactive protein, and insulin resistance.J Cardiometab Syndr. 2006 Summer;1(3):190-6. doi: 10.1111/j.1559-4564.2006.05538.x. J Cardiometab Syndr. 2006. PMID: 17679826 Review.
-
Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.Diabetes Care. 2005 Mar;28(3):690-3. doi: 10.2337/diacare.28.3.690. Diabetes Care. 2005. PMID: 15735209
Cited by
-
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.Br J Pharmacol. 2009 Sep;158(2):395-412. doi: 10.1111/j.1476-5381.2009.00171.x. Epub 2009 Apr 9. Br J Pharmacol. 2009. PMID: 19371337 Free PMC article. Review.
-
Long-term restricted feeding alters circadian expression and reduces the level of inflammatory and disease markers.J Cell Mol Med. 2011 Dec;15(12):2745-59. doi: 10.1111/j.1582-4934.2010.01160.x. J Cell Mol Med. 2011. PMID: 20731750 Free PMC article.
-
Linking cognition and frailty in middle and old age: metabolic syndrome matters.Int J Geriatr Psychiatry. 2015 Jan;30(1):64-71. doi: 10.1002/gps.4115. Epub 2014 Apr 15. Int J Geriatr Psychiatry. 2015. PMID: 24733716 Free PMC article.
-
Racial discrimination and racial identity attitudes in relation to self-rated health and physical pain and impairment among two-spirit American Indians/Alaska Natives.Am J Public Health. 2009 Apr;99 Suppl 1(Suppl 1):S144-51. doi: 10.2105/AJPH.2007.126003. Epub 2009 Feb 12. Am J Public Health. 2009. PMID: 19218182 Free PMC article.
-
Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome.Oncotarget. 2017 May 12;8(44):78144-78152. doi: 10.18632/oncotarget.17839. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100456 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
